News

Once-daily PREZISTA is indicated for the treatment of HIV-1 in treatment-naive and treatment-experienced adult patients with no darunavir resistance-associated mutations. PREZISTA is always taken with and at the

The patent with the latest date of expiry is 2030, without taking into account patent term extension. The three patent applications allowed by the USPTO cover composition of

Taclonex Ointment is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 18 years and older. According to Symphony Health Solutions, brand

The approval is based on the data from an open label, multi-center Phase IV trial designed to evaluate the safety and immunogenicity of a single dose of Adacel

The acquisition elevates Actavis into a top-five position in the Thai generic pharmaceutical market, with leading positions in the ophthalmic and respiratory therapeutic categories and a strong cardiovascular

The research collaboration will be jointly funded by EMD Serono and Pfizer. SLE is a systemic autoimmune disease that can lead to LN, a kidney disorder that is

NESP, a long-acting erythropoiesis stimulating agent, was initially approved in July 2007. NESP is highly recognized for its safety and efficacy for treating anemia of chronic kidney disease

The acquisition positions Charles River as a full service, early-stage contract research organization (CRO), with integrated in vitro and in vivo capabilities from target discovery through preclinical development.

NCCN ORP vice president Diane Paul said this grant from Astellas and Medivation gives investigators at NCCN Member Institutions a remarkable opportunity to study the effectiveness of enzalutamide